Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
|
|
Cash Flow Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-22 | Dec-25-21 | Dec-26-20 | Dec-28-19 | Dec-29-18 | Dec-30-17 | Dec-31-16 | Dec-26-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Net income | 486.2 | 391.0 | 364.3 | 252.0 | 226.4 | 248.9 | 154.8 | 301.4 |
Depreciation and amortization [+] | 303.9 | 265.5 | 234.9 | 198.1 | 161.8 | 131.2 | 126.7 | 94.9 |
Depreciation | 157.3 | 140.7 | 123.0 | 108.6 | 96.9 | 89.8 | 85.0 | 70.7 |
Amortization | 146.6 | 124.9 | 111.9 | 89.5 | 64.8 | 41.4 | 41.7 | 24.2 |
Asset impairment charges | | | | | | 17.2 | 6.7 | 0.2 |
Stock-based compensation | 73.6 | 71.5 | 56.3 | 57.3 | 47.3 | 44.0 | 43.6 | 40.1 |
Deferred taxes | -35.9 | -24.0 | -0.1 | -21.9 | -9.7 | 28.3 | 1.9 | 2.7 |
Change in working capital [+] | -273.9 | 37.4 | -62.8 | 3.4 | -15.7 | 59.0 | 17.4 | 20.4 |
Accounts receivable | -150.6 | -26.6 | -85.6 | -8.3 | -21.2 | -48.3 | -52.8 | -17.0 |
Inventories | -78.5 | -25.2 | -18.4 | -21.4 | -13.3 | -17.8 | -4.0 | 3.4 |
Accounts payable | -2.7 | 44.9 | 0.7 | 29.8 | -12.7 | 0.0 | 22.1 | 1.2 |
Income taxes | | | | | | 121.4 | 42.9 | 24.4 |
Other | -42.2 | 44.3 | 40.5 | 3.4 | 31.6 | 3.7 | 9.3 | 8.4 |
Other operating activities | 65.7 | 19.4 | -46.1 | -8.0 | 31.0 | -210.5 | -34.3 | -152.8 |
Cash from operations | 619.6 | 760.8 | 546.6 | 480.9 | 441.1 | 318.1 | 316.9 | 306.8 |
|
Capital expenditures | -324.7 | -228.8 | -166.6 | -140.5 | -140.1 | -82.4 | -55.3 | -63.3 |
Purchases of property and equipment | -324.7 | -228.8 | -166.6 | -140.5 | -140.1 | -82.4 | -55.3 | -63.3 |
Acquisitions | -283.4 | -1,293.1 | -418.6 | -515.7 | -824.9 | -25.0 | -648.5 | -247.7 |
Sales of short-term investments | 4.5 | 6.5 | 11.4 | 0.9 | 35.8 | 9.1 | 47.7 | 19.7 |
Sales of short-term investments | 4.5 | 6.5 | 11.4 | 0.9 | 35.8 | 9.1 | 47.7 | 19.7 |
Other cash from investing | -4.3 | 77.4 | -27.8 | -26.2 | -25.9 | 25.7 | -36.6 | -36.5 |
Cash from investing | -607.9 | -1,437.9 | -601.5 | -681.5 | -955.0 | -72.6 | -692.7 | -327.6 |
|
Repurchase of common stock, net | -38.7 | -40.7 | -24.0 | -18.1 | -13.8 | -106.9 | -12.3 | -117.5 |
Option exercises | 25.1 | 45.7 | 46.6 | 34.5 | 37.7 | 38.9 | 23.2 | 39.4 |
Financing costs | | -38.3 | | -6.6 | -18.3 | | -3.7 | |
Other cash from financing | 21.4 | 720.7 | 117.8 | 278.0 | 591.2 | -62.7 | 412.6 | 149.6 |
Cash from financing | -42.4 | 672.6 | 47.2 | 231.9 | 558.1 | -208.5 | 380.8 | -7.3 |
|
Free cash flow | 294.9 | 532.0 | 380.0 | 340.4 | 301.1 | 235.6 | 261.6 | 243.6 |
Per share (diluted) | $5.75 | $10.35 | $7.51 | $6.85 | $6.14 | $4.85 | $5.46 | $5.11 |
|
Cash paid for interest | 100.8 | 70.8 | 72.5 | 67.8 | 47.5 | 27.4 | 22.8 | 11.1 |
|